<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1160">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05146050</url>
  </required_header>
  <id_info>
    <org_study_id>2021-FXY-446</org_study_id>
    <nct_id>NCT05146050</nct_id>
  </id_info>
  <brief_title>Olfactory Change After Chemo-radiotherapy for Nasopharyngeal Carcinoma</brief_title>
  <official_title>Changes and Influence Factors of Olfactory Function After Chemo-radiotherapy for Locally Advanced Nasopharyngeal Carcinoma: a Prospective Observational Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational cohort study aimed to explore the changes of olfactory function at&#xD;
      multiple time points from baseline to 1 year after radiotherapy among the local advanced&#xD;
      nasopharyngeal carcinoma patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Newly-diagnosed patients with stage III or IV non-metastatic Nasopharyngeal Carcinoma (AJCC&#xD;
      8th) will be recruited. Olfactory function of consecutive patients with nasopharyngeal&#xD;
      carcinoma was assessed prospectively before treatment and serially up to 1 year after&#xD;
      radiotherapy by the Sniffin' Sticks olfactory function test and by The Questionnaire of&#xD;
      Olfactory Disorders (QOD) as well as a patient symptom visual analogue scale. The change in&#xD;
      olfactory function and it's influence factors in NPC patients who receiving induction&#xD;
      chemotherapy with concurrent chemoradiotherapy will be investigated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Change in bjective olfactory function</measure>
    <time_frame>1.5 years</time_frame>
    <description>Objective olfactory function was assessed was assessed prospectively before treatment and serially up to 1 year after radiotherapy by TDI-score according to the Sniffin' Sticks olfactory function test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change inSubjective olfactory function</measure>
    <time_frame>1.5 years</time_frame>
    <description>The Questionnaire of Olfactory Disorders (QOD) will be used during the assessment from baseline to 1 year after radiotherapy.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">107</enrollment>
  <condition>Nasopharyngeal Carcinoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        nasopharyngeal carcinoma patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-70, regardless of sex.&#xD;
&#xD;
          -  Patients with newly histologically confirmed non-keratinizing nasopharyngeal&#xD;
             carcinoma, type of WHO II or III, clinical stage III-IVa (according to the 8th&#xD;
             American Joint Committee on Cancer [AJCC] edition).&#xD;
&#xD;
          -  ECOG (Eastern Cooperative Oncology Group) score: 0-1.&#xD;
&#xD;
          -  Patients receiving induction chemotherapy with concurrent chemoradiotherap.&#xD;
&#xD;
          -  Patients must sign informed consent and be willing, and well understood the objective&#xD;
             and procedure of this study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women in pregnancy or lactation.&#xD;
&#xD;
          -  Patients who received additional treatment during the observation period due to&#xD;
             disease progression.&#xD;
&#xD;
          -  Patients with significantly lower heart, liver, lung, kidney and bone marrow function.&#xD;
&#xD;
          -  Patient with severe medical condition.&#xD;
&#xD;
          -  with a condition that could cause olfactory dysfunction, such as septum deviation,&#xD;
             nasal polyposis, nasopharyngeal necrosis, congenital olfactory dysfunction, septum&#xD;
             surgery, head trauma, chronic rhinosinusitis, allergic rhinitis, or psychiatric or&#xD;
             neurological disorders, such as Parkinson's, MS and Alzheimer's disease, or long&#xD;
             history of psychiatric drug, corticosteroids or other drug that may affect olfactory&#xD;
             function.&#xD;
&#xD;
          -  Not able to return for evaluation of olfactory function or follow-up (language,&#xD;
             practical implementation, mental condition)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Haiqiang Mai, Dr</last_name>
    <phone>86-20-8734-3643</phone>
    <email>maihq@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qiuyan Chen, Dr</last_name>
    <phone>86-20-8734-3380</phone>
    <email>chenqy@mail.sysu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Haiqiang Mai, MD,Ph.D</last_name>
      <phone>86-20-8734-3643</phone>
      <email>maihq@mail.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Hua MS, Chen ST, Tang LM, Leung WM. Olfactory function in patients with nasopharyngeal carcinoma following radiotherapy. Brain Inj. 1999 Nov;13(11):905-15.</citation>
    <PMID>10579662</PMID>
  </reference>
  <reference>
    <citation>Ho WK, Kwong DL, Wei WI, Sham JS. Change in olfaction after radiotherapy for nasopharyngeal cancer--a prospective study. Am J Otolaryngol. 2002 Jul-Aug;23(4):209-14.</citation>
    <PMID>12105785</PMID>
  </reference>
  <reference>
    <citation>Hölscher T, Seibt A, Appold S, Dörr W, Herrmann T, Hüttenbrink KB, Hummel T. Effects of radiotherapy on olfactory function. Radiother Oncol. 2005 Nov;77(2):157-63. Epub 2005 Oct 13.</citation>
    <PMID>16226328</PMID>
  </reference>
  <reference>
    <citation>Galletti B, Santoro R, Mannella VK, Caminiti F, Bonanno L, De Salvo S, Cammaroto G, Galletti F. Olfactory event-related potentials: a new approach for the evaluation of olfaction in nasopharyngeal carcinoma patients treated with chemo-radiotherapy. J Laryngol Otol. 2016 May;130(5):453-61. doi: 10.1017/S0022215116000761. Epub 2016 Mar 2.</citation>
    <PMID>26931794</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 18, 2021</study_first_submitted>
  <study_first_submitted_qc>November 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Hai-Qiang Mai,MD,PhD</investigator_full_name>
    <investigator_title>Director of the Department of Nasopharyngeal Carcinoma</investigator_title>
  </responsible_party>
  <keyword>Nasopharyngeal Carcinoma</keyword>
  <keyword>Olfactory change</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Nasopharyngeal Carcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

